Effectiveness and Safety of Aldosterone Antagonist Therapy Use Among Older Patients With Reduced Ejection Fraction After Acute Myocardial Infarction
BackgroundWhile aldosterone antagonists have proven benefit among post‐myocardial infarction (MI) patients with low ejection fraction (EF), how this treatment is used among older MI patients in routine practice is not well described. Methods and ResultsUsing ACTION Registry‐GWTG linked to Medicare d...
Main Authors: | Tracy Y. Wang, Amit N. Vora, S. Andrew Peng, Gregg C. Fonarow, Sandeep Das, James A. de Lemos, Eric D. Peterson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.115.002612 |
Similar Items
-
Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure
by: Nappi J, et al.
Published: (2011-06-01) -
Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin–angiotensin–aldosterone system among patients with obesity and proteinuria
by: Enrique Morales, et al.
Published: (2015-11-01) -
Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin–angiotensin–aldosterone system among patients with obesity and proteinuria
by: Enrique Morales, et al.
Published: (2015-11-01) -
Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
by: Yuta Tezuka, et al.
Published: (2021-03-01) -
A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure
by: C McKenna, et al.
Published: (2010-05-01)